VERNON HILLS, Ill.--(BUSINESS WIRE)--Biopharmaceutical company Applied NeuroSolutions, Inc. (OTCBB:APNS)(www.appliedneurosolutions.com) today announced an agreement with Eli Lilly and Company (NYSE:LLY) to develop therapeutics to treat Alzheimer’s disease (AD).
